BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701
/PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug...
Ziping Wei Prnewswire Bliss Biopharmaceutical Hangzhou Co Ltd Eisai Co Ltd United Nations Sustainable Development Goals Sdgs Bliss Biopharmaceutical Hangzhou Co Ltd Co Ltd
Source: prnewswire.com